Skip to content

DocGo DCGO Cost not yet recognized

Cost not yet recognized at other companies

Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's cost not yet recognized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's cost not yet recognized?
DocGo (DCGO) reported cost not yet recognized of $2.53M in Q1 2026.
How has DocGo's cost not yet recognized changed year-over-year?
DocGo's cost not yet recognized decreased by 73.1% year-over-year, from $9.42M to $2.53M.
What is the long-term trend for DocGo's cost not yet recognized?
Over 3 years (2022 to 2025), DocGo's cost not yet recognized has grown at a -57.3% compound annual growth rate (CAGR), from $41.67M to $3.25M.